falseFY201900016816220.010.01150000000150000000380265973837130538026597383713050.04805P5Y00300000000.010.012000000020000000000P12M0100000550.10.0750.0750.0537.6022.6337.6022.6337.6022.6331.0831.0827.7722.8431.4231.42 0001681622 2018-09-29 2019-09-27 0001681622 2020-09-22 2020-09-22 0001681622 2017-09-30 2018-09-28 0001681622 2016-10-01 2017-09-29 0001681622 2018-09-28 0001681622 2019-09-27 0001681622 2017-09-29 0001681622 2016-09-30 0001681622 us-gaap:CommonStockMember 2018-09-29 2019-09-27 0001681622 us-gaap:CommonStockMember 2017-09-30 2018-09-28 0001681622 us-gaap:CommonStockMember 2017-09-29 0001681622 us-gaap:AdditionalPaidInCapitalMember 2018-09-29 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2017-09-30 2018-09-28 0001681622 us-gaap:ParentMember 2017-09-30 2018-09-28 0001681622 us-gaap:RetainedEarningsMember 2017-09-29 0001681622 us-gaap:AdditionalPaidInCapitalMember 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2017-09-29 0001681622 us-gaap:CommonStockMember 2016-10-01 2017-09-29 0001681622 us-gaap:NoncontrollingInterestMember 2018-09-29 2019-09-27 0001681622 us-gaap:ParentMember 2016-10-01 2017-09-29 0001681622 vrex:NetParentInvestmentMember 2016-09-30 0001681622 us-gaap:RetainedEarningsMember 2016-10-01 2017-09-29 0001681622 us-gaap:AdditionalPaidInCapitalMember 2017-09-30 2018-09-28 0001681622 us-gaap:CommonStockMember 2016-09-30 0001681622 us-gaap:RetainedEarningsMember 2017-09-30 2018-09-28 0001681622 vrex:NetParentInvestmentMember 2016-10-01 2017-09-29 0001681622 vrex:NetParentInvestmentMember 2018-09-28 0001681622 us-gaap:RetainedEarningsMember 2018-09-29 2019-09-27 0001681622 us-gaap:AdditionalPaidInCapitalMember 2017-09-29 0001681622 vrex:NetParentInvestmentMember 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:ParentMember 2016-09-30 0001681622 us-gaap:RetainedEarningsMember 2019-09-27 0001681622 us-gaap:CommonStockMember 2018-09-28 0001681622 us-gaap:ParentMember 2018-09-29 2019-09-27 0001681622 us-gaap:ParentMember 2018-09-28 0001681622 us-gaap:ParentMember 2019-09-27 0001681622 us-gaap:RetainedEarningsMember 2016-09-30 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-30 2018-09-28 0001681622 us-gaap:AdditionalPaidInCapitalMember 2016-10-01 2017-09-29 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-10-01 2017-09-29 0001681622 us-gaap:RetainedEarningsMember 2018-09-28 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-29 2019-09-27 0001681622 us-gaap:AdditionalPaidInCapitalMember 2016-09-30 0001681622 us-gaap:AdditionalPaidInCapitalMember 2018-09-28 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:CommonStockMember 2019-09-27 0001681622 vrex:NetParentInvestmentMember 2017-09-29 0001681622 us-gaap:NoncontrollingInterestMember 2016-09-30 0001681622 us-gaap:ParentMember 2017-09-29 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-28 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-29 0001681622 us-gaap:MachineryAndEquipmentMember 2019-09-27 0001681622 us-gaap:MachineryAndEquipmentMember 2018-09-28 0001681622 vrex:BuildingsandLeaseholdImprovementsMember 2019-09-27 0001681622 us-gaap:ConstructionInProgressMember 2019-09-27 0001681622 us-gaap:LandMember 2019-09-27 0001681622 vrex:BuildingsandLeaseholdImprovementsMember 2018-09-28 0001681622 us-gaap:LandMember 2018-09-28 0001681622 us-gaap:ConstructionInProgressMember 2018-09-28 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-09-30 2018-09-28 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-09-29 2019-09-27 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2016-10-01 2017-09-29 0001681622 srt:RestatementAdjustmentMember 2017-09-30 2018-09-28 0001681622 srt:MinimumMember 2018-09-29 2019-09-27 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-09-29 2019-09-27 0001681622 srt:MaximumMember 2018-09-29 2019-09-27 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2019-09-27 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2019-03-29 0001681622 us-gaap:BuildingMember 2018-09-29 2019-09-27 0001681622 vrex:VarianMedicalSystemsInc.Member 2017-01-28 0001681622 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2018-09-29 2019-09-27 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-12-28 0001681622 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2018-09-29 2019-09-27 0001681622 us-gaap:LandImprovementsMember 2018-09-29 2019-09-27 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2017-09-30 2018-09-28 0001681622 vrex:DirectConversionABMember us-gaap:DevelopedTechnologyRightsMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:CustomerRelationshipsMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:CustomerRelationshipsMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:DevelopedTechnologyRightsMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:TradeNamesMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:OrderOrProductionBacklogMember 2019-04-29 0001681622 vrex:DirectConversionABMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:OrderOrProductionBacklogMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:TradeNamesMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:InProcessResearchAndDevelopmentMember 2019-04-29 0001681622 vrex:PerkinElmerInc.Member vrex:IndustrialMember 2017-05-01 2017-09-29 0001681622 vrex:PerkinElmerInc.Member 2017-05-01 2017-09-29 0001681622 vrex:PerkinElmerInc.Member vrex:MedicalMember 2017-05-01 2017-09-29 0001681622 vrex:DirectConversionABMember 2019-04-30 2019-09-27 0001681622 vrex:DirectConversionABMember vrex:IndustrialMember 2019-04-30 2019-09-27 0001681622 vrex:DirectConversionABMember vrex:MedicalMember 2019-04-30 2019-09-27 0001681622 vrex:PerkinElmerInc.Member 2017-05-01 0001681622 vrex:PerkinElmerInc.Member 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member 2016-10-01 2017-09-29 0001681622 vrex:DirectConversionABMember 2019-04-29 2019-04-29 0001681622 vrex:VirtualMediaIntegrationLtd.Member 2018-08-31 2018-08-31 0001681622 vrex:PerkinElmerInc.Member us-gaap:ForeignCountryMember 2017-05-01 0001681622 vrex:DirectConversionABMember 2019-04-30 0001681622 vrex:VirtualMediaIntegrationLtd.Member 2018-08-31 0001681622 vrex:PerkinElmerInc.Member us-gaap:LeaseAgreementsMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:OrderOrProductionBacklogMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:LeaseAgreementsMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:TradeNamesMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:OrderOrProductionBacklogMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:CustomerRelationshipsMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:DevelopedTechnologyRightsMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:DevelopedTechnologyRightsMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:TradeNamesMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:CustomerRelationshipsMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:InProcessResearchAndDevelopmentMember 2017-05-01 0001681622 vrex:VECImagingGmbHCo.KGMember 2018-11-01 2019-09-27 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2019-09-27 0001681622 vrex:VECImagingGmbHCo.KGMember srt:ScenarioForecastMember 2019-12-17 2019-12-17 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2018-09-29 2019-09-27 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2013-10-01 2013-10-31 0001681622 vrex:DpiXHoldingMember 2019-09-27 0001681622 vrex:DpiXHoldingMember 2018-09-29 2019-09-27 0001681622 vrex:DpiXLLCMember 2019-09-27 0001681622 vrex:CETTEENGmbHMember vrex:VECImagingGmbHCo.KGMember 2019-09-27 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2018-09-28 0001681622 vrex:DpiXHoldingMember 2016-10-01 2017-09-29 0001681622 vrex:DpiXHoldingMember 2017-09-30 2018-09-28 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2016-10-01 2017-09-29 0001681622 vrex:VECImagingGmbHCo.KGMember 2019-09-27 0001681622 vrex:DpiXHoldingMember vrex:FixedCostCommitmentsMember 2018-09-29 2019-09-27 0001681622 vrex:DpiXHoldingMember 2018-09-28 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2017-09-30 2018-09-28 0001681622 vrex:LondonFacilityClosingMember 2017-09-30 2018-09-28 0001681622 vrex:SantaClaraFacilityRelocationMember 2017-09-30 2018-09-28 0001681622 vrex:SantaClaraFacilityRelocationMember 2018-09-29 2019-09-27 0001681622 srt:MinimumMember vrex:SantaClaraFacilityRelocationMember 2019-09-27 0001681622 srt:MaximumMember vrex:SantaClaraFacilityRelocationMember 2019-09-27 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2018-09-29 2019-09-27 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-10-01 2017-09-29 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-09-30 2018-09-28 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-29 2019-09-27 0001681622 currency:CHF us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:JPY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:EUR us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:CNY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 currency:CHF us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:EUR us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 currency:CNY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 currency:JPY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-29 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-09-30 2018-09-28 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-10-01 2017-09-29 0001681622 us-gaap:SecuredDebtMember 2019-09-27 0001681622 vrex:OtherDebtMember 2019-09-27 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-09-29 2019-09-27 0001681622 us-gaap:SecuredDebtMember 2018-09-29 2019-09-27 0001681622 us-gaap:SecuredDebtMember 2018-09-28 0001681622 us-gaap:SecuredDebtMember 2017-09-30 2018-09-28 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-09-30 2018-09-28 0001681622 vrex:OtherDebtMember 2018-09-28 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2019-09-27 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-09-28 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-10-10 0001681622 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:LondonInterbankOfferedRateLIBORMember 2017-05-01 2017-05-01 0001681622 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:BaseRateMember 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodOneMember 2017-05-01 2017-05-01 0001681622 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:BaseRateMember 2017-05-01 2017-05-01 0001681622 vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodThreeMember 2017-05-01 2017-05-01 0001681622 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodFiveMember 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:LondonInterbankOfferedRateLIBORMember 2017-05-01 2017-05-01 0001681622 vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 2019-10-08 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-10-10 2018-10-10 0001681622 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:LondonInterbankOfferedRateLIBORMember 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 0001681622 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:FederalFundsEffectiveSwapRateMember 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodTwoMember 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodFourMember 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodFourMember 2017-01-25 2017-01-25 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodTwoMember 2017-01-25 2017-01-25 0001681622 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:IntellectualPropertyMember 2018-09-28 0001681622 vrex:CustomerContractsandSupplierRelationshipsMember 2019-09-27 0001681622 us-gaap:DevelopedTechnologyRightsMember 2018-09-28 0001681622 us-gaap:IntellectualPropertyMember 2019-09-27 0001681622 us-gaap:DevelopedTechnologyRightsMember 2019-09-27 0001681622 vrex:CustomerContractsandSupplierRelationshipsMember 2018-09-28 0001681622 vrex:MedicalMember 2018-09-29 2019-09-27 0001681622 vrex:IndustrialMember 2018-09-29 2019-09-27 0001681622 vrex:IndustrialMember 2019-09-27 0001681622 vrex:MedicalMember 2018-09-28 0001681622 vrex:IndustrialMember 2018-09-28 0001681622 vrex:MedicalMember 2019-09-27 0001681622 vrex:JointVentureInSaudiArabiaMember 2018-09-28 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2015-04-30 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2019-09-27 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember vrex:MeVisMedicalSolutionsAGMeVisMember 2019-09-27 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2015-10-31 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2015-10-01 2015-10-31 0001681622 us-gaap:EmployeeStockMember vrex:A2017ESPPMember 2017-01-01 2017-01-31 0001681622 us-gaap:EmployeeStockOptionMember vrex:A2017ESPPMember 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember vrex:A2017OmnibusStockPlanMember 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember 2019-09-27 0001681622 us-gaap:EmployeeStockMember vrex:A2017ESPPMember 2018-09-29 2019-09-27 0001681622 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockMember vrex:A2017ESPPMember 2017-01-31 0001681622 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:MajorityShareholderMember 2016-10-01 2017-09-29 0001681622 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockMember 2018-09-29 2018-12-28 0001681622 us-gaap:EmployeeStockMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember 2017-09-30 2017-12-29 0001681622 us-gaap:EmployeeStockOptionMember 2018-09-29 2018-12-28 0001681622 us-gaap:EmployeeStockMember 2017-09-30 2017-12-29 0001681622 us-gaap:CostOfSalesMember 2016-10-01 2017-09-29 0001681622 us-gaap:ResearchAndDevelopmentExpenseMember 2017-09-30 2018-09-28 0001681622 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-09-29 2019-09-27 0001681622 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-10-01 2017-09-29 0001681622 us-gaap:CostOfSalesMember 2018-09-29 2019-09-27 0001681622 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-09-30 2018-09-28 0001681622 us-gaap:ResearchAndDevelopmentExpenseMember 2016-10-01 2017-09-29 0001681622 us-gaap:CostOfSalesMember 2017-09-30 2018-09-28 0001681622 us-gaap:ResearchAndDevelopmentExpenseMember 2018-09-29 2019-09-27 0001681622 srt:MaximumMember 2019-09-27 0001681622 srt:MinimumMember 2019-09-27 0001681622 srt:MaximumMember 2018-09-28 0001681622 srt:MinimumMember 2018-09-28 0001681622 us-gaap:OperatingSegmentsMember 2019-09-27 0001681622 us-gaap:OperatingSegmentsMember vrex:MedicalMember 2019-09-27 0001681622 us-gaap:OperatingSegmentsMember vrex:MedicalMember 2018-09-28 0001681622 us-gaap:OperatingSegmentsMember vrex:IndustrialMember 2019-09-27 0001681622 us-gaap:OperatingSegmentsMember vrex:IndustrialMember 2018-09-28 0001681622 us-gaap:OperatingSegmentsMember 2018-09-28 0001681622 srt:LatinAmericaMember 2018-09-29 2019-09-27 0001681622 us-gaap:EMEAMember 2018-09-29 2019-09-27 0001681622 us-gaap:EMEAMember 2018-09-28 0001681622 srt:LatinAmericaMember 2017-09-30 2018-09-28 0001681622 srt:AsiaPacificMember 2018-09-29 2019-09-27 0001681622 srt:AsiaPacificMember 2016-10-01 2017-09-29 0001681622 srt:AsiaPacificMember 2019-09-27 0001681622 country:US 2019-09-27 0001681622 us-gaap:EMEAMember 2019-09-27 0001681622 country:US 2018-09-29 2019-09-27 0001681622 srt:LatinAmericaMember 2018-09-28 0001681622 country:US 2016-10-01 2017-09-29 0001681622 srt:LatinAmericaMember 2016-10-01 2017-09-29 0001681622 srt:LatinAmericaMember 2019-09-27 0001681622 us-gaap:EMEAMember 2016-10-01 2017-09-29 0001681622 country:US 2018-09-28 0001681622 country:US 2017-09-30 2018-09-28 0001681622 srt:AsiaPacificMember 2018-09-28 0001681622 us-gaap:EMEAMember 2017-09-30 2018-09-28 0001681622 srt:AsiaPacificMember 2017-09-30 2018-09-28 0001681622 vrex:IndustrialMember 2017-09-30 2018-09-28 0001681622 vrex:MedicalMember 2017-09-30 2018-09-28 0001681622 vrex:IndustrialMember 2016-10-01 2017-09-29 0001681622 vrex:MedicalMember 2016-10-01 2017-09-29 0001681622 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-29 2019-09-27 0001681622 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-09-29 2019-09-27 0001681622 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-09-29 2019-09-27 0001681622 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-09-28 0001681622 2018-09-29 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-09-29 0001681622 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2019-09-27 0001681622 2019-09-28 2019-09-27 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-09 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-09 2020-06-09 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-04 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-04 2020-06-05 0001681622 us-gaap:SubsequentEventMember 2020-06-04 2020-06-05 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2020-06-06 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 2019-10-08 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 iso4217:USD iso4217:USD xbrli:shares xbrli:pure vrex:member xbrli:shares vrex:entity vrex:employee vrex:segment vrex:derivative iso4217:EUR xbrli:shares vrex:day utreg:Rate


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  ___________________________________
FORM 8-K
 ___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 22, 2020
  ___________________________________
VAREX IMAGING CORPORATION
(Exact name of registrant as specified in its charter)
 ___________________________________
Delaware
(State or other jurisdiction of incorporation or organization)
001-37860
 
81-3434516
(Commission File Number)
 
(I.R.S. Employer
Identification Number)
 
 
 
 
1678 S. Pioneer Road,
Salt Lake City,
Utah
 
84104
 
 
 
 
(Zip Code)
Registrant’s telephone number, including area code: (801) 972-5000
Not Applicable
(Former name or former address, if changed since last report)
 ___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
VREX
The Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b - 2 of the Securities Exchange Act of 1934. Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 8.01
Other Events

As previously reported within Form 10-Q for the quarter ended July 3, 2020 filed on August 14, 2020 (“Form 10-Q”) Varex Imaging Corporation (the “Company”) experienced reduced demand in the Company’s industrial segment and for certain higher end medical products that negatively impacted revenues and gross margin and as a result of the economic downturn resulting from COVID-19. The Company’s Credit Agreement contains financial covenants, including certain leverage ratio covenants. The Company was in compliance with all financial covenants as of July 3, 2020. However, based on the Company’s current forecasts, it was probable that the Company would be in violation of certain leverage ratio covenants contained in its Credit Agreement within the twelve-month period following the issuance of those financial statements, including as early as the end of the Company's fiscal year end 2020. Failure to comply with the covenants, if not amended or waived, would result in an event of default under the Credit Agreement and the acceleration of the outstanding balance of the loans thereunder and cross defaults and accelerations under other agreements. As a result, the Company’s Form 10-Q reported that these events and conditions raise substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period following the issuance of those financial statements.

In Exhibit 99.1 to this Current Report on Form 8-K (i) the Company, in anticipation of certain financing transactions, updated Note 1 of its consolidated financial statements (“Financial Statements”) in its Annual Report on Form 10-K for the year ended September 27, 2019 (the “2019 Form 10-K”) to add an “Impact of COVID-19” discussion as previously disclosed in the Form 10-Q and updated Note 19 to add a discussion of its debt financing activities since December 20, 2019 and (ii) the Company’s independent registered public accounting firm reissued its report contained in the 2019 Form 10-K to include a paragraph noting management’s conclusion regarding the Company’s ability to continue as a going concern. Other than as described in the preceding sentences, Exhibit 99.1 does not revise, modify, update or otherwise affect the 2019 Form 10-K, including the Financial Statements. This Form 8-K and Exhibit 99.1 should be read in conjunction with our other filings made with the SEC, including, and subsequent to, the date of the 2019 Form 10-K.

Item 9.01
Financial Statements and Exhibits
(d)     Exhibits

Exhibit No.
Description
23.1
99.1
101
The following materials from Varex Imaging Corporation’s Annual Report on Form 10-K for the year ended September 27, 2019, filed with the Securities and Exchange Commission on December 20, 2019, as revised by this Current Report on Form 8-K, formatted in Inline XBRL:
(i)  the Consolidated Statements of Operations of the Company for the years ended September 27, 2019, September 28, 2018 and September 29, 2017;
(ii)  the Consolidated Statements of Comprehensive Income of the Company for the years ended September 27, 2019, September 28, 2018 and September 29, 2017;
(iii)  the Consolidated Balance Sheets of the Company as of September 27, 2019 and September 28, 2018;
(iv)  the Consolidated Statements of Cash Flows of the Company for the years ended September 27, 2019, September 28, 2018 and September 29, 2017;
(v)  the Consolidated Statements of Changes in Shareholders’ Equity of the Company for the years ended September 27, 2019, September 28, 2018 and September 29, 2017; and
(vi)  the Notes to the Consolidated Financial Statements.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)







SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
 
VAREX IMAGING CORPORATION
 
 
 
Dated: September 22, 2020
By:
/s/ Kimberley E. Honeysett
 
 
Kimberley E. Honeysett
 
 
Senior Vice President, General Counsel and Corporate Secretary